drugset / Trial / NCT02769494
The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims at evaluating efficacy and safety of topical using Mesalazine Sustained-Release Tablets in in the treatment of oral ulcers in patients with Crohn's disease.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-12
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesalamine | Small molecule | 500 mg | Topical |
| Comparator | Riboflavin | Other / unclassified | — | Topical |